Pygeum for Prostate: What the Research Shows

Pygeum has been quietly prescribed for prostate problems in Europe since 1969, making it one of the oldest herbal treatments for benign prostatic hyperplasia (BPH). Extracted from the bark of the African plum tree (Prunus africana), pygeum for prostate health has been tested in 18 randomised controlled trials involving over 1,500 men.

Yet outside Europe, most men have never heard of it. If you’ve researched pumpkin seed oil, saw palmetto, or beta-sitosterol, pygeum deserves a look. The evidence base is older but surprisingly consistent.

What Is Pygeum?

Pygeum comes from the bark of Prunus africana, a tree native to sub-Saharan Africa and Madagascar. Traditional healers used the bark for urinary complaints long before pharmaceutical companies took notice.

The standardised extract (typically sold as Tadenan or Prunera) contains several active compounds: phytosterols (including beta-sitosterol), pentacyclic triterpenes, and ferulic acid esters. Each targets a different aspect of prostate enlargement, which partly explains why whole-bark extract performs differently from isolated compounds.

France approved pygeum as a prescription treatment for BPH in 1969. By the 1990s, it accounted for roughly 80% of BPH prescriptions in France and was widely used across Italy, Germany, and Austria 1.

How Pygeum Works in the Prostate

Unlike finasteride, which targets a single enzyme, pygeum appears to work through at least four pathways.

Anti-inflammatory action. Pygeum inhibits 5-lipoxygenase, reducing the production of leukotrienes and pro-inflammatory prostaglandins in prostate tissue 2. A 2024 in vitro study confirmed this, showing that pygeum bark extract significantly reduced IL-6 levels (drops of 1,972 to 5,439 pg/mL) and suppressed TNF-alpha across all test concentrations 3.

Growth factor inhibition. Pygeum blocks basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), and insulin-like growth factor-1 (IGF-1) in prostate cells. These growth signals drive the tissue overgrowth that causes BPH symptoms 4.

Androgen receptor blocking. Atraric acid, a compound found in pygeum bark, directly blocks androgen receptors in prostate tissue. This reduces the effect of dihydrotestosterone (DHT) without lowering blood testosterone levels.

Bladder contractility. Pygeum may improve detrusor muscle function, helping the bladder contract more effectively against the resistance caused by an enlarged prostate.

Worth noting: despite these mechanisms, no trial has shown that pygeum shrinks the prostate gland. Like beta-sitosterol, the symptom improvement comes from reduced inflammation and improved muscle tone rather than tissue reduction.

What the Clinical Trials Show

The evidence for pygeum for prostate symptoms comes primarily from European trials conducted between the 1970s and 2000s.

The Cochrane Review

The most authoritative assessment is the Cochrane systematic review, which analysed 18 randomised controlled trials involving 1,562 men 1.

Key findings:

• Men taking pygeum were more than twice as likely to report overall symptom improvement (RR 2.1, 95% CI 1.4 to 3.1)
• Nocturia reduced by 19%
• Peak urine flow increased by 23%
• Residual urine volume decreased by 24%
• The standardised effect size was -0.8 SD, indicating a “moderately large improvement”

Adverse effects were mild and comparable to placebo. The most common complaint was gastrointestinal upset.

The Dosing Study

A randomised, double-blind trial of 209 men compared 50 mg twice daily versus 100 mg once daily over two months, followed by a 10-month open-label extension 5.

Both dosing schedules performed equally well. At two months, IPSS improved 35-38% and peak flow increased by 1.6-2.0 mL/s. By 12 months, IPSS had dropped 46% from baseline, and half of the participants achieved an IPSS below 8 (considered mild symptoms).

This 12-month data is significant because most pygeum trials only ran for 60 days. The extended results suggest benefits are sustained and may continue improving over time.

The Meta-Analysis

An earlier systematic review of 18 studies (also 1,562 men) calculated a weighted mean difference in symptom improvement that was statistically significant compared to placebo 6. The review noted that pygeum was “well tolerated and inexpensive” compared to prescription alternatives.

How Pygeum Compares to Other Prostate Supplements

If you’re deciding between pygeum and other BPH supplements, the evidence picture is worth comparing directly.

Pygeum vs saw palmetto. Saw palmetto is far more popular, but its evidence is weaker. A 2024 Cochrane review of 27 trials (4,656 men) concluded that saw palmetto is no better than placebo for BPH symptoms. Pygeum’s Cochrane review, by contrast, found statistically significant benefits. The catch: pygeum’s trials are older and generally smaller.

Pygeum vs beta-sitosterol. Beta-sitosterol is actually one of the active compounds inside pygeum bark. Standalone beta-sitosterol trials (519 men across 4 RCTs) show consistent symptom improvement, including a Lancet trial with IPSS dropping 7.4 points. Pygeum delivers beta-sitosterol plus additional anti-inflammatory compounds, but there’s no head-to-head trial comparing the two.

Pygeum vs nettle root. Nettle root targets BPH through different mechanisms (SHBG binding, aromatase inhibition). The Sokeland 2000 trial compared nettle root plus saw palmetto against finasteride and found comparable results. Pygeum has more standalone trial data, while nettle root’s best evidence is in combination.

Pygeum vs finasteride. No direct comparison trial exists. Finasteride is proven to shrink the prostate (reducing volume by 20-30%), something pygeum does not do. However, the Cochrane review noted that pygeum’s symptom improvement was “comparable” to finasteride’s, with far fewer sexual side effects. Finasteride causes impotence in about 5% of men; pygeum’s rate in trials was around 1%.

Dosage and How to Take It

The standard dose used across clinical trials is 100-200 mg daily of standardised bark extract, typically containing 14% triterpenes and 0.5% n-docosanol 1.

Both 50 mg twice daily and 100 mg once daily produce equivalent results 5. Once-daily dosing is more convenient and equally effective.

Allow at least 6-8 weeks before judging whether it works for you. The 12-month dosing study showed continued improvement beyond the initial response period.

Take pygeum with food to reduce the small risk of stomach upset.

Side Effects and Safety

Pygeum has a reassuring safety profile across 18 clinical trials. Adverse effects were mild, infrequent, and comparable to placebo rates 1.

The most commonly reported side effects:

• Nausea or stomach discomfort
• Diarrhea or constipation
• Headache (rare)

No serious adverse events were attributed to pygeum in any published trial. Dropout rates were around 12%, similar between treatment and placebo groups.

One concern that has nothing to do with your health: Prunus africana is listed as vulnerable by the IUCN due to overharvesting. Legitimate manufacturers use cultivated or sustainably harvested bark, but it’s worth checking the source.

When to See a Doctor

Pygeum may help with mild to moderate lower urinary tract symptoms, but see a doctor if you experience:

• Blood in your urine (even once)
• Complete inability to urinate (acute urinary retention)
• Pain or burning during urination that doesn’t resolve
• Symptoms that worsen despite supplement use
• Fever or chills alongside urinary symptoms

BPH symptoms can overlap with prostate cancer, urinary tract infections, and chronic prostatitis. A proper diagnosis matters before self-treating with any supplement.

Frequently Asked Questions

Does pygeum work for prostate enlargement?

Pygeum shows modest but consistent benefits for BPH symptoms. A Cochrane review of 18 trials (1,562 men) found that men taking pygeum were twice as likely to report symptom improvement, with nocturia reduced by 19% and peak urine flow increased by 23%. It does not appear to shrink the prostate gland itself.

How long does pygeum take to work?

Most clinical trials measured outcomes at 60 days, with measurable improvements in urinary symptoms and flow rates by that point. One 12-month study showed continued improvement beyond the initial 2-month period, with IPSS scores dropping 46% by month 12 5.

What are the side effects of pygeum?

Side effects are mild and uncommon. The most reported issue is gastrointestinal upset including nausea, stomach pain, or diarrhea. In clinical trials, adverse effect rates were comparable to placebo, and dropout rates were similar between treatment and placebo groups.

Is pygeum better than saw palmetto for prostate?

The evidence arguably favours pygeum. A 2024 Cochrane review concluded that saw palmetto is no better than placebo for BPH, while pygeum’s Cochrane review found a statistically significant benefit. That said, pygeum’s trials are older and smaller. Neither supplement has strong head-to-head comparison data with the other.

Can I take pygeum with other prostate supplements?

Pygeum is sometimes combined with saw palmetto, nettle root, or beta-sitosterol in commercial formulations. No major drug interactions have been reported. If you take prescription BPH medications like finasteride or tamsulosin, talk to your doctor before adding pygeum, as combined effects on urinary function are unstudied.

Summary

Pygeum for prostate symptoms has one of the more solid evidence bases among herbal BPH supplements, with 18 randomised trials and a positive Cochrane review behind it. The benefits are modest: roughly a 19% reduction in nighttime urination, 23% improvement in urine flow, and more than double the likelihood of overall symptom improvement compared to placebo.

It won’t shrink your prostate, and it won’t replace prescription medications for severe symptoms. But for men with mild to moderate BPH who want to try a supplement before committing to drugs, pygeum’s combination of proven efficacy, good tolerability, and low side-effect profile makes it a reasonable option to discuss with your doctor.

References

1. Wilt T, et al. Pygeum africanum for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2002. PubMed
2. Paubert-Braquet M, et al. Effect of Pygeum africanum extract on A23187-stimulated production of lipoxygenase metabolites from human polymorphonuclear cells. J Lipid Mediat Cell Signal. 1994. PubMed
3. Ferrara F, et al. Anti-inflammatory potential of Pygeum africanum bark extract: an in vitro study of cytokine release. Int J Mol Sci. 2024. PubMed
4. Yoshimura Y, et al. The effect of Pygeum africanum on fibroblast growth factor (FGF) and transforming growth factor beta expression in animal model. ResearchGate
5. Chatelain C, et al. Comparison of once and twice daily dosage forms of Pygeum africanum extract in patients with BPH. Urology. 1999. PubMed
6. Ishani A, et al. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis. Am J Med. 2000. PubMed